Taysha Gene Therapies
TSHA
TSHA
109 hedge funds and large institutions have $402M invested in Taysha Gene Therapies in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
5.23% more ownership
Funds ownership: 69.72% → 74.96% (+5.2%)
7% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 27
2% less call options, than puts
Call options by funds: $453K | Put options by funds: $462K
Holders
109
Holding in Top 10
3
Calls
$453K
Puts
$462K
Top Buyers
| 1 | +$29.8M | |
| 2 | +$9.87M | |
| 3 | +$6.31M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$3.73M |
| 5 |
RI
RTW Investments
New York
|
+$3.54M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$5.16M | |
| 3 | -$4.85M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.79M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.28M |